Anabolic effects of human biosynthetic parathyroid hormone fragment (1- 34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits

Journal of Bone and Mineral Research

Volumn 14, Issue 4, 1999, Pages 536-545

  Hirano, Toru ^a   Burr, David B ^a   Turner, Charles H ^a   Sato, Masahiko ^b   Cain, Rick L ^b   Hock, Janet M ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ARTICLE; BIOMECHANICS; BONE MASS; BONE REMODELING; BONE STRENGTH; CALCIUM CELL LEVEL; CORTICAL BONE; FEMALE; HORMONE ACTION; NONHUMAN; OSSIFICATION; RABBIT; TIBIA;

EID: 0033042160     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.4.536     Document Type: Article

References (42)

1. Lindsay R, Tohme JF 1990 Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76:290-295.
2. Storm T, Thamsborg G, Steiniche T, Genant HK, Sorensen OH 1990 Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265-1271.
3. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443.
4. Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut CH III 1984 Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295-303.
5. Bauer E, Aub J, Albright JF 1929 Studies of calcium and phosphorus metabolism: Study of bone trabeculae as readily available reserve supply of calcium. J Exp Med 49:145-162.
6. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709.
7. Gunness-Hey M, Hock JM 1984 Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5:177-181.
8. Liu C-C, Kalu DN 1990 Human parathyroid hormone (1-34) prevents bone loss and auguments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 4:449-458.
9. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R 1993 Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:2479-2487.
10. Ejersted C, Andreassen TT, Oxlund H, Jorgensen PH, Bak B, Haggblad J, Torring O, Nilsson MH 1993 Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097-1101.
11. Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MH 1993 Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394-399.
12. Wronski TJ, Yen CF 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15:51-58.
13. Baumann BD, Wronski TJ 1995 Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247-253.
14. Mosekilde L, Danielsen CC, Sogaard CH, McOsker JE, Wronski TJ 1995 The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model. Bone 16:223-230.
15. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM 1983 Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000-1006.
16. Mackey MS, Stevens ML, Ebert DC, Tressler DL, Combs KS, Lowry CK, Smith PN, McOsker JE 1995 The ferret as a small animal model with BMU-based remodeling for skeletal research. Bone 17:191S-196S.
17. Jerome CP, Johnson CS, Lees CJ 1995 Effect of treatment for 3 months with human parathyroid hormone 1-34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 17:415S-420S.
18. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT Jr 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial. Br Med J 280:1340-1344.
19. Hesp R, Hulme P, Williams D, Reeve J 1981 The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1-34). Metab Bone Dis Rel Res 2:331-334.
20. Slovik DM, Rosenthal DI, Doppelt SH, Potts JT Jr, Daly MA, Campbell JA, Neer RM 1986 Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1:377-381.
21. Reeve J, Davies UM, Hesp R, McNally E, Katz D 1990 Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. BMJ 301:314-318.
22. Hodsman AB, Steer MB, Fraher LJ, Drost DJ 1991 Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients. Bone Miner 14:67-83.
23. Neer M, Slovik DM, Daly N, Potts JT Jr, Nussbaum SR 1993 Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3:S204-S205.
24. Sone T, Fukunaga M, Ono S, Nishiyama T 1995 A small dose of human parathyroid hormone (1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Miner Electrolyte Metab 21:232-235.
25. Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D 1997 A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 82:620-628.
26. Rindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D 1997 Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on estrogen with osteoporosis. Lancet 350:551-555.
27. Inoue J 1985 Bone changes with long-term administration of low doses of 1-34 human PTH in adult beagles. J Jpn Orthop Assoc 59:409-427.
28. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600-613.
29. Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH 1995 The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate - Is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16:603-610.
30. Sietsema WK 1995 Animal models of cortical porosity. Bone 17:297S-305S.
31. Roberts WE, Turley PK, Brezniak N, Fielder PJ1987 Implants: Bone physiology and metabolism. CDA J 15:54-61.
32. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
33. Turner CH, Burr DB 1993 Basic biomechanical measurements of bone: A tutorial. Bone 14:595-608.
34. Hasegawa K, Turner CH, Recker RR, Wu E, Burr DB 1995 Elastic properties of osteoporotic bone measured by scanning acoustic microscopy. Bone 16:85-90.
35. Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M 1997 Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501-506.
36. Waters RV, Vickery BH, Avnur Z, Hirano T, Burr DB 1997 Bone structure and turnover following treatment of glucocorticoid osteopenia in rabbits with RS-66271 and bPTH (1-34). J Bone Miner Res 12:S512.
37. Wu DD, Boyd RD, Fix TJ, Burr DB 1990 Regional patterns of bone loss and altered bone remodeling in response to calcium deprivation in laboratory rabbits. Calcif Tissue Int 47:18-23.
38. Gilsanz V, Roe TF, Gibbens DT, Schulz EE, Carlson ME, Gonzalez O, Boechat MI 1988 Effect of sex steroids on peak bone density of growing rabbits. Am J Phys 255:E416-E421.
39. Cosman F, Lindsay R 1998 Is parathyroid hormone a therapeutic option for osteoporosis? A review of clinical evidence. Calcif Tissue Int 62:475-480.
40. Bourdeau JE, Hesselton RAM 1988 Serum calcium concentrations in wild rabbits. Miner Electrolyte Metab 14:253-256.
41. Vaughan J 1975 The physiology of bone. Clarendon Press, Oxford, U.K.
42. Goad DL, Pecquet ME, Warren HB 1989 Total serum calcium concentrations in rabbits. J Am Vet Assoc 194:1520-1521.